当前位置:
X-MOL 学术
›
Lancet Diabetes Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs.
The Lancet Diabetes & Endocrinology ( IF 44.5 ) Pub Date : 2021-08-20 , DOI: 10.1016/s2213-8587(21)00212-6 Darren K McGuire 1 , Neha J Pagidipati 2
中文翻译:
GLP1 受体激动剂:从抗高血糖药物到心血管药物。
更新日期:2021-08-20
The Lancet Diabetes & Endocrinology ( IF 44.5 ) Pub Date : 2021-08-20 , DOI: 10.1016/s2213-8587(21)00212-6 Darren K McGuire 1 , Neha J Pagidipati 2
Affiliation
中文翻译:
GLP1 受体激动剂:从抗高血糖药物到心血管药物。